Why the Indian Supreme Court’s judgment on combination drugs sends wrong signals

It indicates to High Courts that judges can sidestep the legislative procedures on complex regulatory issues if these are deemed inconvenient.

Dinesh Thakur

 & 

Prashant Reddy T

· Dec 29, 2017 · 02:30 pm

Interview: How South Africa pushed through major reforms to make medicines more affordable

Anban Pillay of South Africa’s health department explains how the country regulated drug prices despite protests by doctors and pharmaceutical companies.

Menaka Rao

· Nov 23, 2017 · 02:30 pm

Proposed e-cigarette ban: Users are up in arms, fear they will return to smoking tobacco

Many users of e-cigarettes say the devices have helped them quit tobacco. But the jury is out on the actual safety of these vapourisers.

Menaka Rao

· Sep 19, 2017 · 02:44 pm

Government proposes a new drugs policy that would give it greater control over medicine pricing

It seeks to provide boost to local industry and curtail the powers of National Pharmaceutical Pricing Authority.

Menaka Rao

· Aug 17, 2017 · 12:30 pm

India makes a long overdue move to ensure better drug safety

The health ministry has made bioequivalence studies compulsory for some generic drugs.

Prashant Reddy

· Apr 12, 2017 · 02:30 pm

Drug pricing authority warns stent manufacturers against creating 'artificial' shortage

Cardiologists have reported that the NPPAs price cap on stents has not stopped cardiac procedures or adversely affected patients so far.

Menaka Rao

· Feb 19, 2017 · 05:45 am

Bedaquiline debate: Domicile requirement for TB patients to get live-saving drug may no longer apply

Authorities allow patient from Patna to get treatment in Delhi, giving hope to others who have the condition.

Menaka Rao

· Jan 21, 2017 · 02:30 pm

Why imminent Indian government regulations on medical devices have everyone worried

While industry is crying foul over stringent provisions on the shelf lives of devices, others argue that the rules do not do nearly enough.

Ankur Paliwal

· Jan 16, 2017 · 02:30 pm

The price of cardiac stents: It is industry against civil society once more

Pharmaceutical bodies want innovation products to be left out of price control but doctors' association want prices of all stents to be regulated.

Menaka Rao

· Jan 14, 2017 · 04:00 pm

The price of cardiac stents will be capped – but no one knows how the new costs will be calculated

Health activists say that the using the regular formula for life-saving drugs would still keep the life-saving devices highly unaffordable.

Menaka Rao

· Dec 23, 2016 · 02:30 pm

Medical apps offer everything from diagnosis to medicine. But can they be trusted?

Doctors see more negatives than positives in the online healthcare world.

Mayank Jain

· Jul 18, 2015 · 12:30 pm